Meaux Cedex, France Clinical Trials

A listing of Meaux Cedex, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 28 clinical trials
FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation

Single-arm, multi-centre phase II study The primary objective is to evaluate the time to failure of the strategy.

neutrophil count
adjuvant chemotherapy
metastasis
folfox regimen
panitumumab
Ch de Meaux
 (0.9 away) Contact site
  • 19 views
  • 05 Mar, 2021
  • +46 other locations
First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI

In Europe, pancreatic cancer (PC) is the 7th most common cancer and the 5th leading cause of cancer death in Europe. Each year, the number of deaths due to prostate cancer is almost as high as the number of new cases diagnosed reflecting the poor prognosis associated with this disease. …

gemcitabine
measurable disease
irinotecan
pancreatic adenocarcinoma
adjuvant chemotherapy
CH
 (0.9 away) Contact site
  • 10 views
  • 22 Jan, 2021
  • +47 other locations
PHASE III RANDOMISED TRIAL TO EVALUATE FOLFOX WITH OR WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY FOR LOCALLY ADVANCED OR METASTATIC OESOPHAGO-GASTRIC CARCINOMA

Gastric cancer is the fourth commonest cancer and the second largest cause of mortality from cancer. Surgical resection of localised forms of gastric cancer offers the only chance of a cure. The vast majority of patients, however, present with advanced disease from the outset (locally advanced or metastatic) or recurrent …

CH
 (22.0 away) Contact site
  • 11 views
  • 26 Jan, 2021
  • +148 other locations
Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over

Colorectal cancer occurs mainly in elderly patients. Recent estimation showed that in France more than 50% of the patients diagnosed with a colorectal cancer are 70 years old or more. Adjuvant chemotherapy has demonstrated a benefit on disease-free survival and overall survival after a stage III colon cancer resection. Nevertheless …

cancer
oxaliplatin
stage iii colon cancer
primary tumor
fluoropyrimidine
CH de Meaux
 (0.9 away) Contact site
  • 31 views
  • 24 Jan, 2021
  • +202 other locations
Study to Improve OS in 18 to 60 Year-old Patients Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

This open label, multicenter phase II/III study with multiple randomization phases at differents stages of AML treatment (induction, consolidation and HSCT where applicable) is designed to improve OS in younger (18 to 60 year-old) patients, with AML risk-adapted patient strategies. Within the intermediate risk AML group, optimal GvHD prophylaxis following …

mycophenolate mofetil
filgrastim
methotrexate
cytarabine
daunorubicin
H pital Avicenne
 (20.6 away) Contact site
  • 42 views
  • 25 Jan, 2021
  • +56 other locations
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients

The Ministry of Health has set the target of eradicating hepatitis C (HCV) in France by 2025. The goal is to validate the feasibility and value of conducting routine HCV screening in hospitalized patients.

Grand H pital de l'Est Francilien - Site de Marne-la-Vall e
 (10.2 away) Contact site
  • 0 views
  • 24 May, 2021
  • +3 other locations
Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL

The aim of the present EWALL-INO study is to confirm very promising results obtained with a combination of INO and mild chemotherapy in older de novo CD22+ B-ALL patients. For that purpose, safety and efficacy of a weekly INO administration combined to mild-intensity chemotherapy will be evaluated in a cohort …

Hopital Avicenne
 (20.6 away) Contact site
  • 10 views
  • 25 Jan, 2021
  • +31 other locations
Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver

Colorectal cancer is the 3rd most common cancer in France and the 2nd cause of death from cancer. Between 30 to 60% of patients develop limited or predominant liver metastases. Surgical resection of these metastases, only curative treatment is not immediately possible in 10-15% of cases. In unresectable patients, current …

vegf
EGFR
metastasis
panitumumab
fluorouracil
CH de Meaux
 (0.9 away) Contact site
  • 1 views
  • 25 Jan, 2021
  • +106 other locations
Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers

This is what the FFCD 11-01 - PRODIGE 25 trial proposes to study, as a preliminary for strategic studies evaluating the usefulness of including targeted therapeutics from the first line with aflibercept +/- LV5FU2.

adenocarcinoma
neutrophil count
aflibercept
metastasis
anticoagulants
CHU APHP H pital Avicenne
 (20.6 away) Contact site
  • 22 views
  • 24 Jan, 2021
  • +89 other locations
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk

Comparison of survival in patients with or without a matched donor at 36 months

blood transfusion
hla-a
anemia
cytopenia
lenalidomide
GHEF, site de Meaux
 (0.9 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +65 other locations